COR Cencora, Inc. Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026COR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
COR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
| Ex-Datum | Split | Typ |
|---|---|---|
| 16. Juni 2009 | 2-for-1 | Vorwärts |
| 29. Dezember 2005 | 2-for-1 | Vorwärts |
| 25. März 1999 | 2-for-1 | Vorwärts |
Über Cencora, Inc. Common Stock Unternehmensübersicht von Wikipedia
Cencora (bis 2023 AmerisourceBergen) ist ein Arzneimittelgroßhändler aus den Vereinigten Staaten mit Firmensitz in Chesterbrook, Pennsylvania. Cencora ist im Finanzindex S&P 500 gelistet. Im Unternehmen sind rund 44.000 Mitarbeiter beschäftigt (Stand: 2022).
AmerisourceBergen entstand 2001 durch die Fusion der Unternehmen Amerisource und Bergen. Im Jahr 2023 übernahm AmerisourceBergen das deutsche Unternehmen PharmaLex, welches Pharmaunternehmen u. a. bei der Zulassung von Medikamenten berät. Im August 2023 firmierte AmerisourceBergen zu Cencora, Inc. um.
Cencora verkauft Medikamente, OTC-Arzneimittel, Gesundheits- und Pflegeprodukte sowie ähnliche Produkte an seine Kunden. Zu den Kunden gehören Apotheken, Kliniken und weitere verschiedene Gesundheitszentren.
Cencora wurde im Februar 2024 erfolgreich von Cyberkriminellen angegriffen. Die Kriminellen stahlen Daten aus den IT-Systemen des Unternehmens.
## Strafzahlungen
Im seit Jahren andauernden Rechtsstreit um süchtig machende Schmerzmittel haben neben Johnson & Johnson die Arzneimittelgroßhändler McKesson, AmerisourceBergen und Cardinal Health einen milliardenschweren Vergleich mit zahlreichen Klägern akzeptiert. Die Arzneimittelgroßhändler McKesson, AmerisourceBergen und Cardinal Health sowie Johnson & Johnson könnten dabei letztlich bis zu 26 Milliarden Dollar zahlen, wie New Yorks Generalstaatsanwältin Letitia James und Generalstaatsanwälte aus etlichen anderen US-Bundesstaaten im Juli 2021 verkündeten.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | COR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 22.95-Jahres-Durchschnitt ≈24.6 | ≈24.6 | 22.9 | Fairer Wert | |
| P/S (TTM) | 0.25-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.5 | Unterbewertet | |
| K/B (MRQ) | 19.35-Jahres-Durchschnitt ≈31.3 | ≈31.3 | · | · | |
| EV / EBITDA | 17.25-Jahres-Durchschnitt ≈12.4 | ≈12.4 | · | · | |
| Kurs / FCF (TTM) | 14.55-Jahres-Durchschnitt ≈13.6 | ≈13.6 | · | · | |
| Kurs / Cashflow (TTM) | 12.25-Jahres-Durchschnitt ≈11.4 | ≈11.4 | 14.0 | Überbewertet | |
| EV / Revenue (EV / Umsatz) | 0.25-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · | |
| EV / FCF | 19.75-Jahres-Durchschnitt ≈14.4 | ≈14.4 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -20.5 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | COR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 4.0%5-Jahres-Durchschnitt ≈3.4% | ≈3.4% | 4.3% | Im Einklang | |
| Betriebsgewinnmarge (TTM) | 0.91%5-Jahres-Durchschnitt ≈0.91% | ≈0.91% | 1.1% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 1.2%5-Jahres-Durchschnitt ≈1.2% | ≈1.2% | 1.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 1.1%5-Jahres-Durchschnitt ≈0.83% | ≈0.83% | 1.0% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 0.79%5-Jahres-Durchschnitt ≈0.62% | ≈0.62% | 0.63% | Spitzenklasse | |
| ROA (TTM) | 3.3%5-Jahres-Durchschnitt ≈2.7% | ≈2.7% | 3.1% | Schwach | |
| ROE (TTM) | 104.3%5-Jahres-Durchschnitt ≈5989.2% | ≈5989.2% | -4.6% | Spitzenklasse | |
| ROIC | 20.2%5-Jahres-Durchschnitt ≈32.6% | ≈32.6% | 12.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | COR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 3.85-Jahres-Durchschnitt ≈5.1 | ≈5.1 | 0.3 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 0.95-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 0.9 | Im Einklang | |
| Quick Ratio | 0.55-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.5 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 3.85-Jahres-Durchschnitt ≈5.1 | ≈5.1 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | COR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 9.3%5-Jahres-Durchschnitt ≈11.1% | ≈11.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 10.4%5-Jahres-Durchschnitt ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.1% | · | · | · | |
| EPS YoY (EPS VjV) | 5.7%5-Jahres-Durchschnitt ≈2.2% | ≈2.2% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 3.0%5-Jahres-Durchschnitt ≈0.63% | ≈0.63% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -0.33% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -2.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | COR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 4.55-Jahres-Durchschnitt ≈4.4 | ≈4.4 | 4.5 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 15.75-Jahres-Durchschnitt ≈15.3 | ≈15.3 | 15.7 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 13.15-Jahres-Durchschnitt ≈13.2 | ≈13.2 | 13.1 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$6.8M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Aug 14, 2026 | $0,60 | USD | ≈0.76% |
| Mai 15, 2026 | $0,60 | USD | ≈0.91% |
| Feb 13, 2026 | $0,60 | USD | ≈0.64% |
| Nov 14, 2025 | $0,60 | USD | ≈0.62% |
| Aug 15, 2025 | $0,55 | USD | ≈0.75% |
| Mai 16, 2025 | $0,55 | USD | ≈0.74% |
| Feb 14, 2025 | $0,55 | USD | ≈0.87% |
| Nov 15, 2024 | $0,55 | USD | ≈0.87% |
| Aug 9, 2024 | $0,51 | USD | ≈0.86% |
| Mai 9, 2024 | $0,51 | USD | ≈0.90% |
| Feb 8, 2024 | $0,51 | USD | ≈0.86% |
| Nov 10, 2023 | $0,51 | USD | ≈0.99% |
| Aug 10, 2023 | $0,49 | USD | ≈1.0% |
| Mai 11, 2023 | $0,49 | USD | ≈1.1% |
| Feb 9, 2023 | $0,49 | USD | ≈1.2% |
| Nov 10, 2022 | $0,49 | USD | ≈2.0% |
| Aug 12, 2022 | $0,46 | USD | ≈2.9% |
| Mai 13, 2022 | $0,46 | USD | ≈4.0% |
| Feb 11, 2022 | $0,46 | USD | ≈4.9% |
| Dez 1, 2021 | $1,27 | USD | ≈7.1% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. September 2026 | Nov 3, 2026 | $4.48 | $4.61 | -2.8% |
| 30. Juni 2026 | $4.48 | $4.39 | 2.0% | |
| 31. März 2026 | $4.75 | $4.86 | -2.3% | |
| 31. Dezember 2025 | $4.08 | $4.08 | 0.03% | |
| 30. September 2025 | $3.84 | $3.82 | 0.41% | |
| 30. Juni 2025 | $4.00 | $3.88 | 3.2% | |
| 31. März 2025 | $4.42 | $4.15 | 6.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.78 | $3.31 | $2.60 | $-1.03 | $1.07 | $-4.99 | $13.92 | $13.76 | $9.47 | $9.68 | $3.06 | $8.82 | |
| Revenue / Share | $1646.05 | $1467.71 | $1281.45 | $1129.62 | $1026.50 | $927.29 | $847.76 | $762.20 | $691.08 | $649.90 | $624290.83 | $507.93 | |
| Cash Flow / Share | $19.85 | $17.40 | $19.12 | $12.80 | $12.79 | $10.78 | $11.07 | $6.41 | $6.79 | $14.07 | $18001.06 | $6.22 | |
| Cash / Share | $22.46 | $16.07 | $12.91 | $16.43 | $12.24 | $22.51 | $16.32 | $11.69 | $11.17 | $12.46 | $10.48 | $8.15 | |
| Dividend / Share | $2.20 | $2.04 | $1.94 | $1.84 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | $1.94 | $1.84 | $1.76 | $1.66 | $1.60 | $1.52 | $1.46 | $1.36 | $1.16 | $0.94 | |
| EPS (TTM) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | · | 193,822,000 | 193,796,000 | 193,758,000 | · | 198,260,000 | 199,406,000 | 200,081,000 | · | 202,349,000 | 202,316,000 | 204,032,000 | · | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | · | 195,230,000 | 195,094,000 | 195,188,000 | · | 200,047,000 | 201,177,000 | 201,837,000 | · | 204,375,000 | 204,256,000 | 206,327,000 | · | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Bilanz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Cashflow
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Rentabilität
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Effizienz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Pro Aktie
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.99 | $17.46 | $9.81 | · | $10.21 | $5.23 | $1.17 | · | $4.70 | $5.43 | $4.57 | · | $3.39 | $1.39 | $-0.88 | · | |
| Revenue / Share | $437.01 | $401.04 | $439.96 | · | $413.17 | $386.76 | $417.48 | · | $371.12 | $340.07 | $357.98 | · | $327.57 | $310.67 | $304.60 | · | |
| Cash Flow / Share | · | · | $-11.80 | · | · | · | $-13.93 | · | · | · | $4.39 | · | · | · | $3.44 | · | |
| Cash / Share | $14.75 | $11.19 | $9.01 | · | $11.51 | $10.21 | $16.63 | · | $16.78 | $10.38 | $14.40 | · | $6.87 | $7.61 | $8.37 | · | |
| Dividend / Share | $0.60 | $0.60 | $0.60 | $0.55 | $0.55 | $0.55 | $0.55 | $0.51 | $0.51 | $0.51 | $0.51 | $0.48 | $0.48 | $0.48 | $0.48 | $0.46 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $0.51 | $0.51 | $0.51 | · | $0.48 | $0.48 | $0.48 | · | |
| EPS (TTM) | $13.47 | $13.05 | $8.33 | · | $9.74 | $8.64 | $7.05 | · | $9.21 | $9.14 | $9.18 | · | $8.21 | $7.78 | $8.24 | · |
Bewertung (TTM)
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $332.77B | $328.68B | $325.78B | · | $316.65B | $310.23B | $303.19B | · | $283.83B | $276.54B | $271.58B | · | $254.43B | $247.54B | $241.81B | · | |
| Net Income TTM | $2.62B | $2.55B | $1.63B | · | $1.90B | $1.69B | $1.40B | · | $1.86B | $1.85B | $1.87B | · | $1.69B | $1.62B | $1.73B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 21.0 | 24.1 | 40.5 | · | 30.8 | 32.2 | 31.9 | · | 24.5 | 26.6 | 22.4 | · | 23.4 | 20.6 | 20.1 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Dividend Yield | 0.87% | 0.75% | 0.69% | · | 0.74% | 0.79% | 0.97% | · | 0.93% | 0.85% | 0.99% | · | 1.0% | 1.2% | 1.2% | · | |
| Earnings Yield | 4.8% | 4.2% | 2.5% | · | 3.2% | 3.1% | 3.1% | · | 4.1% | 3.8% | 4.5% | · | 4.3% | 4.9% | 5.0% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · | |
| Annual Payout | $468M | $459M | $453M | · | $431M | $426M | $421M | · | $414M | $410M | $405M | · | $397M | $395M | $391M | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Umsatz | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Bruttogewinnmarge % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Betriebsgewinnmarge % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Nettoergebnis | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| Verwässerte EPS | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Liquiditätsgrad | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Freier Cashflow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Institutionelle Eigentümer (13F) 1.477 Einreicher · $57.7B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 102 (-61 vs. Vorquartal) | 172 (+38 vs. Vorquartal) | 434 (-96 vs. Vorquartal) | 631 (+82 vs. Vorquartal) | +1.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.976.681.267 | 23.617.117 | 13,84% | Aktien |
| BlackRock, Inc. | $5.154.136.241 | 18.213.783 | 8,94% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.502.993.290 | 12.378.943 | 6,08% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.719.934.713 | 9.611.756 | 4,72% | Aktien |
| STATE STREET CORP | $2.624.351.709 | 9.273.983 | 4,55% | Aktien |
| Walgreens Boots Alliance, Inc. | $2.240.779.050 | 7.473.000 | 3,89% | Aktien |
| JPMORGAN CHASE & CO | $1.674.031.584 | 5.943.657 | 2,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.537.937.572 | 5.454.888 | 2,67% | Aktien |
| Boston Partners | $1.380.607.614 | 4.868.782 | 2,39% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.290.321.167 | 4.559.761 | 2,24% | Aktien |
| FMR LLC | $1.166.548.808 | 4.122.371 | 2,02% | Aktien |
| MORGAN STANLEY | $1.156.333.544 | 4.086.271 | 2,01% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.056.625.082 | 3.733.921 | 1,83% | Aktien |
| NORGES BANK | $700.042.999 | 2.473.825 | 1,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $643.538.307 | 2.274.148 | 1,12% | Aktien |
| Amundi | $630.854.671 | 2.229.326 | 1,09% | Aktien |
| NORTHERN TRUST CORP | $610.936.560 | 2.158.939 | 1,06% | Aktien |
| Invesco Ltd. | $571.968.798 | 2.021.234 | 0,99% | Aktien |
| Capital Research Global Investors | $560.283.987 | 1.979.942 | 0,97% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $507.827.100 | 1.616.563 | 0,88% | Aktien |
| Carmignac Gestion | $494.462.712 | 1.747.363 | 0,86% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483.772.138 | 1.709.563 | 0,84% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $464.203.378 | 1.640.452 | 0,81% | Aktien |
| Mawer Investment Management Ltd. | $421.312.792 | 1.488.843 | 0,73% | Aktien |
| CITADEL ADVISORS LLC | $386.733.768 | 1.366.647 | 0,67% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $376.098.429 | 1.341.795 | 0,65% | Aktien |
| WELLS FARGO & COMPANY/MN | $363.748.157 | 1.285.421 | 0,63% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $353.589.735 | 1.249.522 | 0,61% | Aktien |
| Legal & General Group Plc | $339.555.628 | 1.199.928 | 0,59% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $338.738.459 | 1.197.038 | 0,59% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $332.184.084 | 1.174.269 | 0,58% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313.668.332 | 1.108.447 | 0,54% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $313.605.793 | 1.108.226 | 0,54% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294.327.781 | 1.040.101 | 0,51% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $293.610.144 | 1.037.565 | 0,51% | Aktien |
| DEUTSCHE BANK AG\ | $286.672.606 | 1.013.049 | 0,50% | Aktien |
| BANK OF MONTREAL /CAN/ | $283.474.139 | 1.001.746 | 0,49% | Aktien |
| Bank of New York Mellon Corp | $280.138.471 | 989.959 | 0,49% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $268.966.547 | 950.479 | 0,47% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $261.162.604 | 922.901 | 0,45% | Aktien |
| Caisse de depot et placement du Quebec | $258.709.937 | 914.234 | 0,45% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $256.926.548 | 907.932 | 0,45% | Aktien |
| HSBC HOLDINGS PLC | $218.870.090 | 773.956 | 0,38% | Aktien |
| Nuveen, LLC | $210.167.248 | 742.693 | 0,36% | Aktien |
| National Pension Service | $208.758.025 | 737.713 | 0,36% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $205.281.694 | 653.472 | 0,36% | Aktien |
| UBS Group AG | $187.855.707 | 663.848 | 0,33% | Aktien |
| Burgundy Asset Management Ltd. | $174.893.972 | 599.753 | 0,30% | Aktien |
| Balyasny Asset Management L.P. | $172.225.024 | 608.612 | 0,30% | Aktien |
| FIRST TRUST ADVISORS LP | $171.654.879 | 606.597 | 0,30% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 Einreichungen | 9. Juni 2025 | 4,96% | Änderung | · | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23. Januar 2015 | · | Erste Einreichung | · | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 Einreichungen | 16. Januar 2015 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 49 Insider · 24 Führungskräfte · 28 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 20. Februar 2026 M | 65.393 | 0 | 6 | $-8.921.514 |
| David R Yost | CEO | 17. Mai 2011 M | 1.530.341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29. Juni 2026 A | · | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 9. November 2018 M | 53.505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 2. Mai 2011 M | 89.698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15. Februar 2007 A | 176.400 | 0 | 0 | $0 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 1. September 2026 S | 16.169 | 0 | 2 | $-1.704.680 |
| Elizabeth S Campbell | Executive Vice President | 24. August 2026 S | 19.455 | 0 | 3 | $-5.399.779 |
| Silvana Battaglia | Executive Vice President | 30. Juni 2026 A | 23.624 | 0 | 1 | $-578.565 |
| Pawan Verma | EVP, Chief Data & Info Officer | 20. November 2025 M | 5.148 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16. September 2025 M | 305.913 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28. Juni 2024 A | 9.525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31. Mai 2024 S | 13.284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20. Dezember 2021 G | 81.367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21. Februar 2020 M | 6.906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23. Mai 2019 S | 1.085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 4. April 2018 M | 47.989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17. November 2017 F | 3.010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 9. November 2016 A | 34.195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29. April 2016 F | 8.897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13. November 2015 F | 5.224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13. November 2015 M | 4.068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 1. Februar 2010 M | 27.190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27. Februar 2008 A | 25.728 | 0 | 0 | $0 |
| Lon R Greenberg | Direktor | 16. September 2026 S | 17.128 | 0 | 1 | $-411.264 |
| Lauren M Tyler | Direktor | 31. Juli 2026 A | 4.456 | 1 | 0 | $148.626 |
| Dennis M Nally | Direktor | 31. Juli 2026 A | 13.188 | 0 | 0 | $0 |
| Ellen Cooper | Direktor | 31. Juli 2026 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Direktor | 18. Juni 2026 P | 31.767 | 2 | 0 | $2.161.800 |
| Werner Baumann | Direktor | 5. März 2026 A | 3.687 | 0 | 0 | $0 |
| Redonda Miller | Direktor | 5. März 2026 A | 3.751 | 0 | 0 | $0 |
| Frank Clyburn | Direktor | 5. März 2026 A | 1.724 | 0 | 0 | $0 |
| Lorence H. Kim | Direktor | 5. März 2026 A | 4.081 | 0 | 0 | $0 |
| Lori Ryerkerk | Direktor | 5. März 2026 A | 1.073 | 0 | 0 | $0 |
| Richard W Gochnauer | Direktor | 11. März 2024 M | 28.762 | 0 | 0 | $0 |
| Kathleen W Hyle | Direktor | 11. März 2024 M | 24.406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Direktor | 9. März 2023 A | 20.479 | 0 | 0 | $0 |
| Jane E Henney MD | Direktor | 5. März 2023 M | 24.685 | 0 | 0 | $0 |
| Michael J Long | Direktor | 5. März 2023 M | 17.724 | 0 | 0 | $0 |
| Douglas R Conant | Direktor | 4. März 2019 M | 8.062 | 0 | 0 | $0 |
| Richard C Gozon | Direktor | 29. Februar 2016 M | 51.484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Direktor | 2. März 2015 M | 3.351 | 0 | 0 | $0 |
| Charles H Cotros | Direktor | 7. Dezember 2012 M | 26.773 | 0 | 0 | $0 |
| Lawrence J Wilson | Direktor | 1. Mai 2009 A | 35.942 | 0 | 0 | $0 |
| Rodney H Brady | Direktor | 19. Februar 2007 A | 52.746 | 0 | 0 | $0 |
| James R Mellor | Direktor | 3. Januar 2006 M | 32.246 | 0 | 0 | $0 |
| Robert E Martini | Direktor | 23. Januar 2004 G | 1.602.739 | 0 | 0 | $0 |
| Francis G Rodgers | Direktor | 3. November 2003 A | 7.918 | 0 | 0 | $0 |
| James F Cleary | · | 11. März 2026 M | 160.357 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 144 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IYK · iShares Trust | 2,77% | 119.649 SH | 11. September 2026 | Täglich |
| MEDI · Harbor ETF Trust | 2,75% | 3.634 NS | 31. Juli 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,07% | 11.071 SH | 2. Oktober 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,07% | 604 NS | 31. Juli 2026 | N-PORT |
| IWP · iShares Trust | 1,76% | 1.052.697 SH | 11. September 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,63% | 512.605 SH | 2. Oktober 2026 | Täglich |
| QIDX · Spinnaker ETF Series | 1,62% | 2.029 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,58% | 44.525 SH | 2. Oktober 2026 | Täglich |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 31. Juli 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,44% | 84.485 SH | 2. Oktober 2026 | Täglich |
| USMV · iShares Trust | 1,29% | 950.181 SH | 11. September 2026 | Täglich |
| ESMV · iShares Trust | 1,27% | 308 SH | 11. September 2026 | Täglich |
| SRHQ · Elevation Series Trust | 1,09% | 7.437 NS | 31. Juli 2026 | N-PORT |
| FLAG · Global X Funds | 1,05% | 57 NS | 31. Juli 2026 | N-PORT |
| ACWV · iShares, Inc. | 1,02% | 106.118 SH | 11. September 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1.187.313 SH | 19. August 2026 | Täglich |
| RPV · Invesco Exchange-Traded Fund Trust | 0,86% | 46.458 SH | 2. Oktober 2026 | Täglich |
| IMCG · iShares Trust | 0,86% | 106.924 SH | 11. September 2026 | Täglich |
| UPSD · ETF Series Solutions | 0,84% | 3.174 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,83% | 87.910 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 0,79% | 102.385 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,77% | 555.571 SH | 19. August 2026 | Täglich |
| JOET · Virtus ETF Trust II | 0,77% | 6.009 NS | 31. Juli 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,69% | 3.828 NS | 31. Juli 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,69% | 271.095 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,62% | 19.269 SH | 2. Oktober 2026 | Täglich |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,59% | 3.418 NS | 31. Juli 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4.005.623 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,44% | 765.286 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,43% | 22.670 SH | 11. September 2026 | Täglich |
| EGUS · iShares Trust | 0,42% | 363 SH | 11. September 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,42% | 590.000 | 2. Oktober 2026 | Täglich |
| HUSV · First Trust Exchange-Traded Fund III | 0,36% | 859 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,35% | 245 SH | 11. September 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 4.845 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 4.747 NS | 31. Juli 2026 | N-PORT |
| QLC · FlexShares Trust | 0,32% | 10.304 NS | 31. Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,29% | 12.016 NS | 31. Juli 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,29% | 13.140.000 | 2. Oktober 2026 | Täglich |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 22.587 NS | 31. Juli 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,27% | 144 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,26% | 7.454.000 | 2. Oktober 2026 | Täglich |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,24% | 7.341.000 | 2. Oktober 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,24% | 4.081 NS | 31. Juli 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,24% | 1.099.165 SH | 19. August 2026 | Täglich |
| ROUS · Lattice Strategies Trust | 0,24% | 5.327 NS | 31. Juli 2026 | N-PORT |
| ESGU · iShares Trust | 0,23% | 130.785 SH | 11. September 2026 | Täglich |
| VFMV · VANGUARD WELLINGTON FUND | 0,23% | 3.466 SH | 19. August 2026 | Täglich |
| SIZE · iShares Trust | 0,23% | 3.006 SH | 11. September 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,22% | 5.440 SH | 2. Oktober 2026 | Täglich |
| IVE · iShares Trust | 0,21% | 323.349 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,21% | 12.308 SH | 11. September 2026 | Täglich |
| VTV · VANGUARD INDEX FUNDS | 0,20% | 1.756.569 SH | 19. August 2026 | Täglich |
| IUSV · iShares Trust | 0,20% | 170.505 SH | 11. September 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 603.720 SH | 2. Oktober 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,20% | 14.313 NS | 31. Juli 2026 | N-PORT |
| ILCG · iShares Trust | 0,19% | 18.808 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,19% | 3.430 NS | 31. Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,19% | 44.794 SH | 19. August 2026 | Täglich |
| CHRI · Global X Funds | 0,18% | 47 NS | 31. Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,18% | 701.921 SH | 11. September 2026 | Täglich |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 26.772 NS | 31. Juli 2026 | N-PORT |
| SUSL · iShares Trust | 0,17% | 6.522 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,17% | 4.484 SH | 2. Oktober 2026 | Täglich |
| DSI · iShares Trust | 0,17% | 28.360 SH | 11. September 2026 | Täglich |
| IQSU · New York Life Investments ETF Trust | 0,17% | 1.753 NS | 31. Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 295.897 SH | 19. August 2026 | Täglich |
| EGLE · Global X Funds | 0,14% | 10 NS | 31. Juli 2026 | N-PORT |
| MPLY · Strategy Shares | 0,14% | 72 NS | 31. Juli 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,14% | 5 NS | 31. Juli 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,14% | 681 NS | 31. Juli 2026 | N-PORT |
| ESG · FlexShares Trust | 0,13% | 540 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,12% | 187.650 NS | 31. Juli 2026 | N-PORT |
| DGRO · iShares Trust | 0,12% | 157.215 SH | 11. September 2026 | Täglich |
| TOPC · iShares Trust | 0,12% | 118 SH | 11. September 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,11% | 6.182 SH | 2. Oktober 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,11% | 45.101 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,11% | 2.244 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,10% | 161 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,10% | 10.695 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,10% | 15 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,10% | 10.075 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,10% | 199 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,10% | 11 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,10% | 2.452.388 SH | 11. September 2026 | Täglich |
| PTLC · Pacer Funds Trust | 0,09% | 9.855 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,09% | 3.743 SH | 11. September 2026 | Täglich |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 26.634 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,09% | 3.268 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,09% | 1.134 SH | 2. Oktober 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,09% | 5.054.054 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,09% | 42.230 SH | 19. August 2026 | Täglich |
| IYY · iShares Trust | 0,09% | 8.360 SH | 11. September 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,09% | 32.060 SH | 2. Oktober 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,09% | 734 NS | 31. Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,09% | 128.996 SH | 11. September 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,09% | 4.663 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,09% | 253.304 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,08% | 56.816 NS | 31. Juli 2026 | N-PORT |
| USCL · iShares Trust | 0,08% | 7.402 SH | 11. September 2026 | Täglich |
| BKLC · BNY Mellon ETF Trust | 0,08% | 14.460 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,08% | 51.452 SH | 11. September 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,08% | 15 NS | 31. Juli 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,08% | 215.874 SH | 19. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 2.429 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,08% | 30.901 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,08% | 716 NS | 31. Juli 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,08% | 150 SH | 2. Oktober 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,07% | 1.355 NS | 31. Juli 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,07% | 15.211 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,07% | 5.868.746 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,07% | 15.724 SH | 19. August 2026 | Täglich |
| TOK · iShares Trust | 0,07% | 496 SH | 11. September 2026 | Täglich |
| QLV · FlexShares Trust | 0,07% | 344 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,07% | 4.582 NS | 31. Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,07% | 16.562 SH | 10. September 2026 | Täglich |
| ISVL · iShares Trust | 0,06% | 24.428 SH | 11. September 2026 | Täglich |
| ACWI · iShares Trust | 0,06% | 58.615 SH | 9. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,05% | 16.160 SH | 2. Oktober 2026 | Täglich |
| GTOS · Invesco Actively Managed Exchange-T… | 0,05% | 59.000 | 2. Oktober 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 175.380 SH | 19. August 2026 | Täglich |
| GTO · Invesco Actively Managed Exchange-T… | 0,03% | 815.000 | 2. Oktober 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 3.552 SH | 2. Oktober 2026 | Täglich |
| IEUS · iShares Trust | 0,02% | 4.214 SH | 11. September 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 0,02% | 13 NS | 31. Juli 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31. Juli 2026 | N-PORT |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 143.002 SH | 19. August 2026 | Täglich |
| SCZ · iShares Trust | 0,01% | 135.615 SH | 11. September 2026 | Täglich |
| IEFA · iShares Trust | 0,00% | 47.650 SH | 11. September 2026 | Täglich |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 575.116 SH | 19. August 2026 | Täglich |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 96.258 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 370.569 SH | 19. August 2026 | Täglich |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
COR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
12 Analysten · 2026-10-01Mittelwert-Ziel $369.25 +19,5%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | · | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | · |
| ACH | · | · | · | · | · | · |
| MEDS | · | · | · | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.